Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.
New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...
New formulation of its widely-used U.S. market-leading PSMA PET imaging agentcombines thediagnostic performance of PYLARIFY® (piflufolastat F 18) ...
1 Laboratory of Physics and Chemistry, Faculty of Science and Technology, Iba Der Thiam University of Thiès, Thiès, Senegal. 2 Laboratory of Biophysics, Joint Research Unit for Exploration and ...
A study from Karolinska Institutet, published in the journal Molecular Psychiatry, offers new insights into the progression of Alzheimer's disease (AD). The research reveals critical differences in ...
A positron emission tomography (PET) scan is a diagnostic tool that examines body tissue functioning, such as blood flow, oxygen use, and sugar metabolism, to help doctors diagnose and treat disease.
Abstract: Positron emission tomography (PET) image quality in both clinical and preclinical environments highly depends on an accurate knowledge of the detector hardware to correct for image quality ...
Dr. Mathieu Spriet is an Associate Professor of Diagnostic Imaging at the School of Veterinary Medicine at the University of California-Davis. In 2015, the Grayson-Jockey Club Research Foundation ...
The Foresight CLARITY test offers greater prognostic accuracy than PET/CT scans in large B-cell lymphoma by detecting ctDNA-MRD negativity, indicating better patient outcomes. ctDNA-MRD testing showed ...